BCK Capital Management’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

BCK Capital Management’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,573	Closed	-$867	–	92
2022 Q4	$867	Hold	13,573	–	–	﹤0.01%	71
2022 Q3	$1K	Hold	13,573	–	–	﹤0.01%	91
2022 Q2	$1K	Hold	13,573	–	–	﹤0.01%	95
2022 Q1	$3K	Buy	+13,573	New	+$4.33K	﹤0.01%	139

BCK Capital Management's BIOTW Position: Q1 2023 in Review

BCK Capital Management sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 13,573 shares — an estimated $867 sold.

BCK Capital Management first reported a position in BIOTW in Q1 2022 and held it in 4 quarters. The position peaked at $3K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

BCK Capital Management reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
BCK Capital Management sold 13,573 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $867.
BCK Capital Management first reported a position in Biotech Acquisition Company Warrant in Q1 2022 and held it in 4 quarters.
BCK Capital Management's Biotech Acquisition Company Warrant position peaked at $3K in Q1 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on BCK Capital Management's 13F filing for Q1 2023, filed 12 May 2023.